These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24246588)

  • 1. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.
    Reid RD; McDonnell LA; Riley DL; Mark AE; Mosca L; Beaton L; Papadakis S; Blanchard CM; Mochari-Greenberger H; O'Farrell P; Wells GA; Slovinec D'Angelo ME; Pipe AL
    CMAJ; 2014 Jan; 186(1):23-30. PubMed ID: 24246588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family-centered brief intervention for reducing obesity and cardiovascular disease risk: A randomized controlled trial.
    Duncan S; Goodyear-Smith F; McPhee J; Zinn C; Grøntved A; Schofield G
    Obesity (Silver Spring); 2016 Nov; 24(11):2311-2318. PubMed ID: 27616217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences on effectiveness of a school-based physical activity intervention for reducing cardiometabolic risk: a cluster randomized trial.
    Martínez-Vizcaíno V; Sánchez-López M; Notario-Pacheco B; Salcedo-Aguilar F; Solera-Martínez M; Franquelo-Morales P; López-Martínez S; García-Prieto JC; Arias-Palencia N; Torrijos-Niño C; Mora-Rodríguez R; Rodríguez-Artalejo F
    Int J Behav Nutr Phys Act; 2014 Dec; 11():154. PubMed ID: 25491026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.
    Ijzelenberg W; Hellemans IM; van Tulder MW; Heymans MW; Rauwerda JA; van Rossum AC; Seidell JC
    BMC Cardiovasc Disord; 2012 Sep; 12():71. PubMed ID: 22962863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.
    Ruffin MT; Nease DE; Sen A; Pace WD; Wang C; Acheson LS; Rubinstein WS; O'Neill S; Gramling R;
    Ann Fam Med; 2011; 9(1):3-11. PubMed ID: 21242555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
    Christiansen MK; Jensen JM; Brøndberg AK; Bøtker HE; Jensen HK
    Vasc Health Risk Manag; 2016; 12():219-27. PubMed ID: 27307744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
    Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
    BMC Res Notes; 2012 Jul; 5():181. PubMed ID: 22490761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial.
    Selvaraj FJ; Mohamed M; Omar K; Nanthan S; Kusiar Z; Subramaniam SY; Ali N; Karanakaran K; Ahmad F; Low WH;
    BMC Fam Pract; 2012 Oct; 13():97. PubMed ID: 23046818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary factors are associated with coronary heart disease risk factors in college students.
    Fernandes J; Arts J; Dimond E; Hirshberg S; Lofgren IE
    Nutr Res; 2013 Aug; 33(8):647-52. PubMed ID: 23890354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina.
    Caselli C; De Caterina R; Smit JM; Campolo J; El Mahdiui M; Ragusa R; Clemente A; Sampietro T; Clerico A; Liga R; Pelosi G; Rocchiccioli S; Parodi O; Scholte A; Knuuti J; Neglia D;
    Sci Rep; 2021 Oct; 11(1):20714. PubMed ID: 34671067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diet and moderate exercise on central obesity and associated disturbances, myocardial infarction and mortality in patients with and without coronary artery disease.
    Singh RB; Rastogi V; Rastogi SS; Niaz MA; Beegom R
    J Am Coll Nutr; 1996 Dec; 15(6):592-601. PubMed ID: 8951737
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.